HCTI
Healthcare Triangle, Inc.
There isn't enough reported data to score HCTI yet.
HCTI Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Unavailable | |
| Unavailable |
HCTI's revenue is currently strong, but its profitability is weak. There isn't enough data to rate its cash flow and balance sheet.
HCTI PE Valuation
HCTI has no meaningful PE right now: it lost money over the past year.
HCTI Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| High |
Analysts expect HCTI's losses to grow, with revenue growing.
HCTI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q1 2025 | -$262,944.00 | +$19,558.66 |
| Q4 2024 | -$337,644.00 | +$48,323.57 |
HCTI lost $262,944.00 per share over the past year, about the same as its loss the year before.
HCTI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $9.2M | +158% |
| Q1 2026 | $9.9M | +166% |
| Q4 2025 | $3.1M | +43% |
| Q3 2025 | $3.5M | +45% |
| Q2 2025 | $3.6M | +19% |
| Q1 2025 | $3.7M | -9.9% |
| Q4 2024 | $2.2M | -69% |
| Q3 2024 | $2.4M | -69% |
HCTI's revenue is recovering but still below its 2022 peak: $9M last quarter, up 158% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -44% | -6.1 points |
| Q1 2026 | -37% | +1 points |
| Q4 2025 | -142% | -119 points |
| Q3 2025 | -74% | -26 points |
| Q2 2025 | -38% | +8 points |
| Q1 2025 | -38% | +3.8 points |
| Q4 2024 | -23% | -3.4 points |
| Q3 2024 | -48% | -29 points |
HCTI's operating margin was −44% last quarter, down 6.1 points from the same quarter a year ago.
HCTI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q1 2026 | -$6.9M | -$1.3M |
| Q4 2023 | $594K | +$2.8M |
| Q2 2023 | -$1.2M | -507% |
| Q1 2023 | -$1.6M | -631% |
| Q4 2022 | -$2.2M | +$1.2M |
HCTI has burned cash in most quarters: −$21M over the past year, against −$4M the year before.
HCTI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +201% | +93.7K shares |
| 1 year | +779217% | +140K shares |
HCTI has 140,277 diluted shares, up 779217% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2022 | $51,000 |
HCTI Net Leverage
HCTI's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
HCTI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.8 | Neutral |
| Stochastic | 0.2 | Oversold |
HCTI's weekly RSI is 33 (neutral) and its Stochastic is 0 (oversold).
HCTI PE vs Healthcare Sector
HCTI has no meaningful PE right now: it lost money over the past year.
HCTI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $8.37 | 55% below |
| 20 week MA | $18.1 | 79% below |
| 50 week MA | $269.1 | 99% below |
| 100 week MA | $34,100.7 | 100% below |
| 200 week MA | $360,400.1 | 100% below |
HCTI is in a downtrend: it's below all five of its weekly moving averages, and 100% below its 200-week average.
HCTI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $10,338,480.0 | $5,378,400.0 | -48% |
| 2022 | $5,378,400.0 | $624,492.0 | -88% |
| 2023 | $624,492.0 | $815,724.0 | +31% |
| 2024 | $815,724.0 | $237,130.7 | -71% |
| 2025 | $237,130.7 | $1,380.0 | -99% |
| 2026 YTD | $1,380.0 | $3.74 | -100% |
HCTI has finished lower in four of the last five years. It's down 100% so far in 2026.